Search for: "Ely Lilly"
Results 281 - 300
of 2,173
Sort by Relevance
|
Sort by Date
15 Feb 2019, 12:47 am
Joost DuijmOn 16 January 2019, the District Court of The Hague ruled that the Dutch part of Eli Lilly and Company’s patent EP 1 313 508 is valid. [read post]
14 Feb 2019, 3:03 pm
Eli Lilly & Co., 598 F.3d 1336, 1351 (Fed. [read post]
9 Feb 2019, 3:45 am
Bart van WezenbeekRelevant prior art may prove not to be useful as a starting point for an attack on inventive step if the prior art teaching is negated by later studies before the effective date of the patent claims. [read post]
6 Feb 2019, 4:27 am
Ever since Actavis v Eli Lilly ([2017] UKSC 48) dragged equivalence into the UK patent infringement system there has been an open question regarding the future of the so-called 'Gillette defence'. [read post]
5 Feb 2019, 1:19 am
Based on the Pemetrexed-decision of the German Federal Supreme Court (docket-no X ZR 29/15, also known as Actavis v Eli Lilly), the Court of Appeal made it clear that Swiss-type claims are to be treated in the same way as so-called EPC 2000-claims. [read post]
4 Feb 2019, 2:01 am
The new year sees the issue of yet another UK court case applying the doctrine of equivalents as established by the UK Supreme Court in Actavis v Eli Lilly ([2017] UKSC 48) ("Actavis"). [read post]
31 Jan 2019, 11:23 am
” Eli Lilly & Co. v. [read post]
30 Jan 2019, 9:19 pm
Eli Lilly & Co. [read post]
25 Jan 2019, 12:00 am
Sources[1] Eli Lilly and Company. (2019, January 7). [read post]
22 Jan 2019, 8:09 am
Eli Lilly case The Actavis ./. [read post]
17 Jan 2019, 11:09 pm
In many circumstances, she had to make a decision because the law required it but it was not necessarily the best thing for the family.Inevitably there was some discussion about the implications of Actavis v Eli Lilly [2017] UKSC 48. [read post]
16 Jan 2019, 9:42 pm
Eli Lilly. [read post]
11 Jan 2019, 4:00 am
In the UK, the Supreme Court in 2017 released its decision in Actavis UK Ltd v Eli Lilly & Co [2017] UKSC 48 which allowed for variants in claim construction. [read post]
29 Dec 2018, 6:30 am
Sara MoranApplying the so-called ‘Actavis Questions’ (further to the Supreme Court decision in Actavis v Eli Lilly), the Court of Appeal reached a different conclusion from the Patents Court on the issue of infringement. [read post]
29 Dec 2018, 2:17 am
| Book Review: Kerly’s Law of Trade Marks and Trade Names | Thursday Thingies | Around the IP BlogsNever Too Late 204 [Week ending 28 Oct]Court of Appeal reaffirms UK as SEP litigation hotspot in upholding Birss J in Unwired Planet | Much Ado About FRAND: What you need to know about today's Court of Appeal Unwired Planet decision | AIPPI UK Rapid Response Event: Unwired Planet v Huawei - 13 November at 6PM | Lord Kitchin applies the "markedly different" infringement… [read post]
21 Dec 2018, 9:14 am
This arose in the context of the drug Tadalafil which treats male erectile dysfunction and has a European patent owned by ICOS and exclusively licensed to Eli Lilly. [read post]
20 Dec 2018, 6:09 am
Before actually dealing with Teva, he walked the audience through Medeva, Actavis v Sanofi (C-443/12) as well as Eli Lilly v HGS (C-493/12) (both judgments issued on 12 December 2013). [read post]
19 Dec 2018, 9:49 am
| Book Review: Kerly’s Law of Trade Marks and Trade Names | Thursday Thingies | Around the IP BlogsNever Too Late 204 [Week ending 28 Oct] Court of Appeal reaffirms UK as SEP litigation hotspot in upholding Birss J in Unwired Planet | Much Ado About FRAND: What you need to know about today's Court of Appeal Unwired Planet decision | AIPPI UK Rapid Response Event: Unwired Planet v Huawei - 13 November at 6PM | Lord Kitchin applies the "markedly different" infringement… [read post]
14 Dec 2018, 7:55 pm
Sara MoranThe Court of Appeal overturned the Patent Court’s first instance decision concerning the validity of one of ICOS’s patents (licensed to Eli Lilly) covering a 1 to 5mg dosage form of tadalafil (Cialis®) for oral administration up to a maximum of 5mg per day for the treatment of sexual dysfunction. [read post]
11 Dec 2018, 5:50 am
First panel discussion: Pros and Cons of Different Patent Litigation Systems in Europe The first panel was composed of Ivan Burnside (Eli Lilly), George Moore (Mylan) and Clemens Heusch (Nokia) giving their personal in-house counsel perspectives on different patent litigation systems based on their experience with parallel cases in many European jurisdictions.One of the key points to emerge from this discussion was that judges must be educated by appropriate experts in the… [read post]
